15 research outputs found
The Bell Child: A YA Horror Novel
No full textThe Bell Child is a YA novel that centers around themes of loneliness and friendship, set against a backdrop of technology rooting its way into our organic places.Embargo status: Restricted until 09/2173. To request the author grant access, click
on the PDF link to the left
Kolob Canyon Review Spring 2015
No full textStaff. Editor-in-Chief Tristen Fagg. Literature Submissions Editor Rachael Kissell. Part Time Reading Staff Kellie Dougal, David Pridmore, Gardner Stevenett, Rebekah Tobler. Full Time Reading Staff Andrew Baruffi, David Baxley, Allison Borzoni, Jay Brewington, Chris Christiansen, Devin Jackman, Amber Midgley, Andie Minert, Cory Morrill, Turner Wilson. Art Director Stephanie Hammer. Content Editor Jordan Youngberg. Layout and Design Staff Stephanie Hammer, Jordan Youngberg. Faculty Advisors Wynne Summers, Jay Merryweather. Editor's Note Included (from Tristen Fagg. Table of Content. Poetry. "A Certain Kind of Coffee," Amy Henderson; "A Love Poem from the Gutter," David Baxley; "Acrid is a Word Unpleasant," Chris Jones; "Adeus," Chase Harrison; "Bottles," Emalee Smith; "Buffalo Plains," Gardner Ted Stevenett; "Change," C.S. Lay; "Christmas Day," Chase Harrison; "Climbing Fear," Chris Jones; "Come," Emalee Smith; "Cosmic Calendar," Corey Morrill; "Death of a Hippie," Kellie Dougal; "Dissection," Allison Borzoni; "Dream Drops," Steven Thomas Devereaux; "Epitaph for a boy," Chris Christiansen; "For Your Eyes Only," Russell Bunge; "From Tea to the Sea," Roxanne Peterson; "Hoodoos," Amber Midgley; "Idle worship," Corey Morrill; "Marie Antoinette-le poisson," Amber Midgley; "Memory," Jill Wagstaff; "Missing Pieces," David Baxley; "Now Past," Hannah Ouderkirk; "On My Way to Work: October 9, 2014," David Pridmore; "Spring," Emily Smith; "Static," Rachael Kissell; "Stout Canyon," Adam Crosby; "Streaked Glass," Steven Thomas Deveraux; "The Beach," Christina Osborn; "The Cosmos," Chris Jones; "The Mommy Lottery," Kellie Dougal; "To Kill a Sitting Bird," Mckay West; "Unpinned," Steven Thomas Deveraux; "Waiting for Tea," Devin Jackman; "What the Children of Hamelin Heard," Jay Brewington; "White Hope in a Canvas of Rust-colored Space," Annalise Liberatore; "Winter 1966," Christina Osborn; "Winter's Road," Megan Wesko; "Youth from Pennsylvania," Chris Christiansen. Fiction. "Letters to Life," Allison Borzoni; "The Missing Sock," Adam Crosby; "Watch Your Back," Amanda Mills; "Working Voices of (More or Less) Kindred Souls," Gardner Ted Stevenett. Creative Non-Fiction. "Catch of Life," Brantz Woolsey; "Checkstand #6," Aubrey Boneck; "Gokyo Ri," Megan Wesko; "Jam," Brantz Woolsey; "Small Miracles," Katrina Tindall; "The Hitchhiker," Christina Osborn; "When She Was Gone," Rachael Kissell. Non-Fiction. "The Ghosts of Julie Simon," Amber Midgley; "Place Narrative Playtime with Phyllis Barber," Tristen Fagg. Editor's Pick. "Sub specie aeternitatis," Chris Christiansen. Faculty Pick. "Yuck," Matt Howard. Staff Pick. "Sea Green," Corey Morrill. Past Pick - 2014 Edition. "Something Like Love," Gardner Ted Stevenett. High School Prize Winner. "Pretty Little Girls," Miriam Schryver, Canyon View High School. Bios. Staff Bios. Art. Work. Anthony Pearson; Carley Prestwich; Marcus Najec; Rachelle Bonnett; Susan Harris; Chelsea Howells; Danelle Cheney; Sarai Trueblood; Jay Merryweather; Jeff Hanson; Jordan Youngberg; Stephanie Hammer; Leesa McLemore; Alena Vandenhazel; Steven Swift; Katrina Christensen; Rebecca Moore; April McPherson; Mallory Peterson; Yidan Guo
To an Indiscernible Heart
No full textTo an Indiscernible Heart compiles visual art and poems to explore the author\u27s experiences with anxiety, grief, relationships, and learning how to navigate change and life lessons. Themes travel across four sections, each marked by a different piece of visual art: \u27Trip into the Unsaid,\u27 \u27Sugarcoat,\u27 \u27Undertow Confessions,\u27 and \u27Speed Painting through Comfort Zones.\u27 Featuring craft elements including enjambment, repetition, and erasure, the collection pulls readers into the rocky nature of learning how to human
Recommended from our members
Use of CONSORT Criteria for Reporting Randomized Controlled Trials in Pharmacy Journals
No full textClass of 2012 AbstractSpecific Aims: To explore whether publishing requirements for human-centered randomized control trials, particularly the CONSORT criteria, have any relationship to impact as measured by the Journal Citation Reports ™ Impact Factor. Methods: A worksheet was used to evaluate a methodically selected list of journals, including types of articles published, requirements of authors for human-focused randomized control trials, JCR Impact Factor and other JCR metrics for each specific journal title. A worksheet was filled out for each journal by each member of the research team and answers combined for consensus. Group means and SDs were calculated and the Student’s t-Test applied to values for selected journals. Main Results: 50 candidate pharmacy journals were identified and 41 met the criteria for publishing human-centered randomized control trials. Journals were grouped according to whether they required CONSORT or had other reporting requirements for human RCTs, or had no requirements for such studies. Few (6; 15%) pharmacy journals required authors to use CONSORT; and additional 15 (37%) journals provided as least some author guidelines similar to CONSORT. Pharmacy journals using CONSORT or other guidelines had a higher average impact factor (3.5; SD = 1.5) than did journals without guidelines (2.4; SD = 0.9; p = 0.007). Conclusions: There appears to be a statistical difference in average JCR metrics between journals which require specific RCT guidelines and those which do not. The use of reporting guidelines, such as CONSORT, by pharmacy journals is associated with increased impact as represented by JCR influence measures.This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Librarian and Clinical Instructor, Pharmacy Practice and Science, [email protected]
Morbidity and Mortality Weekly Report (MMWR)
No full textVaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monkeypox commenced shortly after confirmation of the first monkeypox case in the current outbreak in the United States on May 17, 2022 (1). To date, more than 27,000 cases have been reported across all 50 states, the District of Columbia (DC), and Puerto Rico.* JYNNEOS vaccine is licensed by the Food and Drug Administration (FDA) as a 0.5-mL 2-dose series administered subcutaneously 28 days apart to prevent smallpox and monkeypox infections (2) and has been found to provide protection against monkeypox infection during the current outbreak (3). The U.S. Department of Health and Human Services (HHS) allocated 1.1 million vials of JYNNEOS vaccine from the Strategic National Stockpile, with doses allocated to jurisdictions based on case counts and estimated size of population at risk (4). However, initial vaccine supplies were severely constrained relative to vaccine demand during the expanding outbreak. Some jurisdictions with highest incidence responded by prioritizing first dose administration during May-July (5,6). The FDA emergency use authorization (EUA) of 0.1 mL dosing for intradermal administration of JYNNEOS for persons aged 6518 years on August 9, 2022, substantially expanded available vaccine supply| (7). The U.S. vaccination strategy focuses primarily on persons with known or presumed exposures to monkeypox (8) or those at high risk for occupational exposure (9). Data on monkeypox vaccine doses administered and reported to CDC by U.S. jurisdictions were analyzed to assess vaccine administration and completion of the 2-dose series. A total of 931,155 doses of JYNNEOS vaccine were administered and reported to the CDC by 55 U.S. jurisdictions during May 22-October 10, 2022. Among persons who received 651 dose, 51.4% were non-Hispanic White (White), 22.5% were Hispanic or Latino (Hispanic), and 12.6% were non-Hispanic Black or African American (Black). The percentages of vaccine recipients who were Black (5.6%) and Hispanic (15.5%) during May 22-June 25 increased to 13.3% and 22.7%, respectively, during July 31-October 10. Among 496,888 persons who received a first dose and were eligible for a second dose during the study period, 57.6% received their second dose. Second dose receipt was highest among older adults, White persons, and those residing in the South U.S. Census Bureau Region. Tracking and addressing disparities in vaccination can reduce inequities, and equitable access to and acceptance of vaccine should be an essential factor in planning vaccination programs, events, and strategies. Receipt of both first and second doses is necessary for optimal protection against Monkeypox virus infection
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
No full textReplication-deficient adenoviral vectors have been under investigation as a platform technology for vaccine development for several years and have recently been successfully deployed as an effective COVID-19 counter measure. A replication-deficient adenoviral vector based on the simian adenovirus type Y25 and named ChAdOx1 has been evaluated in several clinical trials since 2012. The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) was formed to evaluate the safety and other key features of new platform technology vaccines. This manuscript reviews key features of the ChAdOx1-vectored vaccines. The simian adenovirus Y25 was chosen as a strategy to circumvent pre-existing immunity to common human adenovirus serotypes which could impair immune responses induced by adenoviral vectored vaccines. Deletion of the E1 gene renders the ChAdOx1 vector replication incompetent and further genetic engineering of the E3 and E4 genes allows for increased insertional capability and optimizes vaccine manufacturing processes. ChAdOx1 vectored vaccines can be manufactured in E1 complementing cell lines at scale and are thermostable. The first ChAdOx1 vectored vaccines approved for human use, against SARS-CoV-2, received emergency use authorization in the UK on 30th December 2020, and is now approved in more than 180 countries. Safety data were compiled from phase I-III clinical trials of ChAdOx1 vectored vaccines expressing different antigens (influenza, tuberculosis, malaria, meningococcal B, prostate cancer, MERS-CoV, Chikungunya, Zika and SARS-CoV-2), conducted by the University of Oxford, as well as post marketing surveillance data for the COVID-19 Oxford-AstraZeneca vaccine. Overall, ChAdOx1 vectored vaccines have been well tolerated. Very rarely, thrombosis with thrombocytopenia syndrome (TTS), capillary leak syndrome (CLS), immune thrombocytopenia (ITP), and Guillain-Barre syndrome (GBS) have been reported following mass administration of the COVID-19 Oxford-AstraZeneca vaccine. The benefits of this COVID-19 vaccination have outweighed the risks of serious adverse events in most settings, especially with mitigation of risks when possible. Extensive immunogenicity clinical evaluation of ChAdOx1 vectored vaccines reveal strong, durable humoral and cellular immune responses to date; studies to refine the COVID-19 protection (e.g., via homologous/heterologous booster, fractional dose) are also underway. New prophylactic and therapeutic vaccines based on the ChAdOx1 vector are currently undergoing pre-clinical and clinical assessment, including vaccines against viral hemorrhagic fevers, Nipah virus, HIV, Hepatitis B, amongst others
Creighton University School of Law Class of 2015
No full textGraduates|Aldrich, Hoken J.; Andrews, Natalie M.; Ang, Isaiah Eduard T.; Barber, Daneis S.; Bartman, Patrick J.; Barto, Emalee P.; Berger, Tyler A.; Betita, Ronald C. (3L Representative); Bohm, Erick R.; Borer, Jacob L.; Brann-Sellnow, Melissa J.; Brasher, Jocelyn J.; Carberry, Leanne E.; Carmondy, Molly M.; Connealy, Conrad F.; Cordon, Nolan D.; Cox, Bryan J.; Crnkovich, Ryan S.; Danehey, Sean P.; DiBona, Justin A.; Dike, Ian P.; Dillard, Connor B.; Dohmen, Barbra R.; Dopheide, MaKenna J.; Drent, Mark G.; Elliott, Ellee M.; Fischer, Hannah K.; FitzPatrick, Matthew G.; Fleming, Kaylen K. (President); Frampton, Nikkie M.; Gorby, Connor L.; Gosar, Ellysa H.; Gosnold-Parker, Andrea V.; Greenwood, S. Ryan; Grevengoed, Tyler J.; Griffin, Kevin R.; Halberg, Cayle M.; Hamit, Kraig R.; Harper, Adam W.; Hassett, Colleen M.; Heims, Amanda J.; Henninger, Mallory M.; Higginson, Robert N.; Hoeft, Kortnei N.; Hofer, Janae L.; Horgan, Thomas E.; Hurley, John A.; Huse, Susan M.; Igbokwe, Ikechukwu N. (Vice President); Jeter, Kimberly B.; Johnson, Charles J.; Katherman, Julianne M.; Keit, Brian F.; Kilcoin, Kati M.; Kitchin, Zachary D.; Koehn, Jay D.; Korrapati, Sri L.; Kunz, Jeffrey M.; Lesiak, Nicholas F.; Li, Elizabeth C.; Lindstedt, Whitney S.; Lombardi, Nicholas J.; Lutz-Priefert, Megan E.; Lutz-Priefert, Zachary W.; Maxwell, Daniel B.; McCarthy, Kevin F.; McMahon, Daniel D.; McWilliams, John A.; Mediate, Carmine V.; Metzger, David L.; Micek, Lauren J.; Moore, Ashley A.; Moscrip, Michael D.; Moses, Dru M.; Muelleman, Daniel J.; Mullaney, Alexis S.; Munger, Andrew M.; Nelsen, Jacob G.; Nielsen, Nicholas S.; Olson, John H.; Osuala, Augustine C.; Owen, James A.; Packer, Scott J.; Page, Adam C.; Pearson, Skyler H.; Pee, Clifton M.; Pham, Anh Phung Ngoc; Powers, Katherine R.; Raver, Amanda E.; Reyes, Claire L.; Richardson, Justin L.; Romriell, Darren W.; Rowberry, Michael G.; Sang, Stephanie R.; Schaefer, Robert T.; Selde, Joseph H.; Sharma, Shivani; Sheikh, Hassan A. (3L Representative); Sikinyi, Consolata N.; Sindelar, Natalie M. (Secretary); Smith, Landon B.; Stamm, Peter W., Jr.; Stensrud, Jared F.; Tarr, Patrick P.; Thomas, Jason R.; Troia, Carl J., III; True, Derek; Tucker, Keith R.; Vila, Aubrey D.; Ward, Thomas N.; Webb, Chase C.; Weiler, Kelsey M.; Wesley, Kevin R.; Whipple, Tonya L.; White, Kelly; Wiggam, Carlton W.; Wilkerson, Franklin B.; Wilson, Dane A.; Wright, Alexis M.; Wright, Anna M.; Zagotta, Peter M.; Zarse, Josh T.; Foster, Jesse J. (not pictured); Wasler, Erik F. (not pictured)|40 x 30 in. (landscape
Iowa History and Culture : A Bibliography of Materials Published Between 1952 and 1986, 1989
No full textThis bibliography was compiled by two reference librarians, Patricia Dawson and David Hudson with the goal of making it easier of tracking down material on Iowa history and culture. This supplements the Iowa History Reference Guide published in 1952 by William Petersen
Parkinson’s Disease Treatments: Treating Symptoms Through Group Power Movements Or Passive Forced Cycling
No full text
